search
Back to results

Resuscitation Strategies in Septic Shock (ReSSeS)

Primary Purpose

Septic Shock, Critically Ill

Status
Unknown status
Phase
Not Applicable
Locations
Netherlands
Study Type
Interventional
Intervention
Transpulmonary Thermodilution
Surviving Sepsis Guidelines (SSG)
Sponsored by
Medisch Spectrum Twente
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Septic Shock focused on measuring Septic shock, Critically ill patients, Transpulmonary thermodilution, Fluid resuscitation

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Age > 18 years
  2. Clinical evidence of sepsis (microbiology confirmation, radiological or direct view (pus in biological fluid) or direct surgical view).
  3. ≥ 2 SIRS criteria:

    1. Temperature < 36.0°C or > 38.0°C
    2. Heart rate > 90 bpm
    3. Respiratory rate > 20 rpm or PaCO2 < 4.2 kPa or need of mechanical ventilation.
    4. Leukocytes > 12.0 x109/L or < 4.0 x109/L or >10% bands
  4. Circulatory shock defined as sustained systemic hypotension (systolic arterial pressure <90 mmHg or MAP <65 mmHg (<75 mmHg in a hypertensive patient) despite a 1,000 ml IV fluid challenge over 30 min (including IV fluids administered pre-ICU) or the need for vasopressor therapy. Hypertensive patients are patients with a history of confirmed hypertension treated with antihypertensive agents.
  5. Mechanical ventilation by endotracheal tube (any form)

Exclusion Criteria:

  1. Pregnancy
  2. Pre-terminal illness with life expectancy <28 days
  3. Duration of circulatory shock >6 hours
  4. Severe peripheral arterial vascular occlusion disease (Fontaine level III-IV)
  5. Inability for femoral artery canulation
  6. No informed consent

Sites / Locations

  • Medisch Spectrum TwenteRecruiting

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Active Comparator

Arm Label

Transpulmonary thermodilution (TPTD)

Surviving Sepsis Guidelines (SSG)

Arm Description

The intervention group (TPTD guided therapy) follows a fluid resuscitation protocol based on stroke volume variation (SVV) and extravascular lung water (EVLW). Initial trigger for fluid loading when circulatory insufficiency is present will be SVV.

The standard group (SSG guided therapy) follows a fluid resuscitation protocol based on the Surviving Sepsis Campaign recommendations. Initial trigger for fluid loading when circulatory insufficiency is present will be the CVP (target ≥12 mmHg).

Outcomes

Primary Outcome Measures

ventilator free days (VFDs)
VFDs from enrolment to extubation until day 28

Secondary Outcome Measures

duration of circulatory shock (hours)
Duration of circulatory shock, defined as the amount of consecutive hours on vasopressor therapy

Full Information

First Posted
May 19, 2014
Last Updated
November 20, 2014
Sponsor
Medisch Spectrum Twente
search

1. Study Identification

Unique Protocol Identification Number
NCT02150512
Brief Title
Resuscitation Strategies in Septic Shock
Acronym
ReSSeS
Official Title
Resuscitation Strategies in Septic Shock. A Randomized Controlled Trial of Two Different Fluid Loading Strategies in ICU Patients With Early Septic Shock
Study Type
Interventional

2. Study Status

Record Verification Date
November 2014
Overall Recruitment Status
Unknown status
Study Start Date
November 2014 (undefined)
Primary Completion Date
October 2016 (Anticipated)
Study Completion Date
December 2016 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Medisch Spectrum Twente

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study, in mechanically ventilated septic shock patients, is to determine whether a fluid loading strategy based on parameters derived from the transpulmonary thermodilution technique may lead to more ventilator free days compared to a fluid loading strategy based on the surviving sepsis guidelines.
Detailed Description
Rationale: Fluid loading is an important intervention in patients with severe sepsis and septic shock in order to prevent development of multi organ failure and mortality. The Surviving Sepsis Guidelines recommend during the first 6 hours of resuscitation a central venous pressure (CVP) based fluid loading approach, targeting to 12-15 mmHg in mechanically ventilated patients. CVP however has proven to be a poor indicator for preload and preload dependency, while dynamic parameters as stroke volume variation (SVV) derived from the transpulmonary thermodilution technique (TPTD) are superior. Together with the ability to measure the extravascular lung water (EVLW), the TPTD technique may guide fluid management more accurately and may prevent deleterious fluid overloading. Objective: The risk of fluid overloading in mechanically ventilated patients with septic shock is less when fluid administration is based on a fluid loading protocol using SVV together with EVLW measurements than applying the Surviving Sepsis Guidelines targeting CVP to 12-15 mmHg, in at least the first 6 hours of resuscitation, translating in more ventilator free days (VFDs) Study design: This is a prospective, randomized, non-blinded, single-center, controlled clinical trial comparing two different fluid resuscitation strategies in patients with septic shock. Patients will be randomized for fluid management based on the Surviving Sepsis Guidelines (SSG) or based transpulmonary thermodilution (TPTD) derived SVV and EVLW in at least the first 6 hours of resuscitation. Study population: All patients of ≥18 years admitted to the ICU because of septic shock together with the need for mechanical ventilation are eligible for randomization Intervention: During at least the first 6 hours of resuscitation, the standard group (SSG guided therapy) follows a fluid resuscitation protocol based on the Surviving Sepsis Campaign recommendations. Initial trigger for fluid loading when circulatory insufficiency is present will be the CVP (target ≥12 mmHg). The intervention group (TPTD guided therapy) follows a fluid resuscitation protocol based on SVV and EVLW. Initial trigger for fluid loading when circulatory insufficiency is present will be SVV. The study protocol will be applied up to a maximum of 72 hours. Main study parameters/endpoints: VFDs on day 28. Benefit and risks associated with participation: Since inclusion criteria include a TPTD (5F fiber optic, femoral artery) catheter, the inconvenience as compared to standard treatment is minimal. Current routine hospital policy involves TPTD catheter insertion in most of the patients meeting the inclusion criteria specified above.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Septic Shock, Critically Ill
Keywords
Septic shock, Critically ill patients, Transpulmonary thermodilution, Fluid resuscitation

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
170 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Transpulmonary thermodilution (TPTD)
Arm Type
Experimental
Arm Description
The intervention group (TPTD guided therapy) follows a fluid resuscitation protocol based on stroke volume variation (SVV) and extravascular lung water (EVLW). Initial trigger for fluid loading when circulatory insufficiency is present will be SVV.
Arm Title
Surviving Sepsis Guidelines (SSG)
Arm Type
Active Comparator
Arm Description
The standard group (SSG guided therapy) follows a fluid resuscitation protocol based on the Surviving Sepsis Campaign recommendations. Initial trigger for fluid loading when circulatory insufficiency is present will be the CVP (target ≥12 mmHg).
Intervention Type
Device
Intervention Name(s)
Transpulmonary Thermodilution
Other Intervention Name(s)
PiCCO, Pulsion Medical Systems, Germany
Intervention Description
Initial trigger for fluid loading when circulatory insufficiency is present will be SVV. If SVV ≤10% in patients on controlled mechanical ventilation with tidal volumes of ≥8 ml/kg, fluid loading will not be performed. If SVV >10% or spontaneous breathing efforts are present, a fluid challenge should be performed. Also if patients are on controlled mechanical ventilation with tidal volumes of ≤7 ml/kg, a fluid challenge should be performed. If fluid responsiveness is present and SVV decreases to ≤10%, further fluid loading should be stopped. If SVV is still >10%, the increase in EVLW will decide whether to continue fluid loading or not; if EVLW is ≥12 mL/kg PBW and EVLW increases upon fluid loading, further fluid loading should be stopped.
Intervention Type
Device
Intervention Name(s)
Surviving Sepsis Guidelines (SSG)
Intervention Description
Initial trigger for fluid loading when circulatory insufficiency is present will be the CVP (target ≥12 mmHg). If circulatory insufficiency is absent, fluid loading will not be initiated or stopped independently of the actual CVP level.
Primary Outcome Measure Information:
Title
ventilator free days (VFDs)
Description
VFDs from enrolment to extubation until day 28
Time Frame
28 days
Secondary Outcome Measure Information:
Title
duration of circulatory shock (hours)
Description
Duration of circulatory shock, defined as the amount of consecutive hours on vasopressor therapy
Time Frame
72 hours
Other Pre-specified Outcome Measures:
Title
mortality
Description
ICU mortality plus 30-days and 90-days mortality
Time Frame
30 days and 90 days
Title
RIFLE-F score
Description
Evolution of renal function (RIFLE-F score) during the first 5 days after inclusion and use of renal replacement therapy (RRT)
Time Frame
5 days
Title
fluid balance
Description
Fluid balances during the first 5 days after inclusion
Time Frame
5 days
Title
length of stay in the ICU
Description
Length of stay in the ICU
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Age > 18 years Clinical evidence of sepsis (microbiology confirmation, radiological or direct view (pus in biological fluid) or direct surgical view). ≥ 2 SIRS criteria: Temperature < 36.0°C or > 38.0°C Heart rate > 90 bpm Respiratory rate > 20 rpm or PaCO2 < 4.2 kPa or need of mechanical ventilation. Leukocytes > 12.0 x109/L or < 4.0 x109/L or >10% bands Circulatory shock defined as sustained systemic hypotension (systolic arterial pressure <90 mmHg or MAP <65 mmHg (<75 mmHg in a hypertensive patient) despite a 1,000 ml IV fluid challenge over 30 min (including IV fluids administered pre-ICU) or the need for vasopressor therapy. Hypertensive patients are patients with a history of confirmed hypertension treated with antihypertensive agents. Mechanical ventilation by endotracheal tube (any form) Exclusion Criteria: Pregnancy Pre-terminal illness with life expectancy <28 days Duration of circulatory shock >6 hours Severe peripheral arterial vascular occlusion disease (Fontaine level III-IV) Inability for femoral artery canulation No informed consent
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
RJ Trof, MD PhD
Phone
0031-53-4872000
Email
r.trof@mst.nl
First Name & Middle Initial & Last Name or Official Title & Degree
M Burgmeijer
Phone
0053-4872000
Email
researchIC@mst.nl
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
RJ Trof, MD PhD
Organizational Affiliation
Medisch Spectrum Twente, department of Intensive Care
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
A Beishuizen, MD PhD
Organizational Affiliation
Medisch Spectrum Twente, department of Intensive Care
Official's Role
Study Director
Facility Information:
Facility Name
Medisch Spectrum Twente
City
Enschede
Country
Netherlands
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
RJ Trof, MD PhD
Email
r.trof@mst.nl
First Name & Middle Initial & Last Name & Degree
Research IC
Email
researchIC@mst.nl
First Name & Middle Initial & Last Name & Degree
RJ Trof, MD PhD
First Name & Middle Initial & Last Name & Degree
A Beishuizen, MD PhD
First Name & Middle Initial & Last Name & Degree
JW Vermeijden, MD

12. IPD Sharing Statement

Learn more about this trial

Resuscitation Strategies in Septic Shock

We'll reach out to this number within 24 hrs